AFA-Recur: an ESC EORP AFA-LT registry machine-learning web calculator predicting atrial fibrillation recurrence after ablation

AIMS Atrial fibrillation (AF) recurrence during the first year after catheter ablation remains common. Patient-specific prediction of arrhythmic recurrence would improve patient selection, and, potentially, avoid futile interventions. Available prediction algorithms, however, achieve unsatisfactory performance. Aim of the present study was to derive from ESC-EHRA Atrial Fibrillation Ablation Long-Term Registry (AFA-LT) a machine-learning scoring system based on pre-procedural, easily accessible clinical variables to predict the probability of 1-year arrhythmic recurrence after catheter ablation. METHODS AND RESULTS Patients were randomly split into a training (80%) and a testing cohort (20%). Four different supervised machine-learning models (decision tree, random forest, AdaBoost, and k-nearest neighbour) were developed on the training cohort and hyperparameters were tuned using 10-fold cross validation. The model with the best discriminative performance on the testing cohort (area under the curve-AUC) was selected and underwent further optimization, including re-calibration. A total of 3128 patients were included. The random forest model showed the best performance on the testing cohort; a 19-variable version achieved good discriminative performance [AUC 0.721, 95% confidence interval (CI) 0.680-0.764], outperforming existing scores (e.g. APPLE score: AUC 0.557, 95% CI 0.506-0.607). Platt scaling was used to calibrate the model. The final calibrated model was implemented in a web calculator, freely available at http://afarec.hpc4ai.unito.it/. CONCLUSION AFA-Recur, a machine-learning-based probability score predicting 1-year risk of recurrent atrial arrhythmia after AF ablation, achieved good predictive performance, significantly better than currently available tools. The calculator, freely available online, allows patient-specific predictions, favouring tailored therapeutic approaches for the individual patient.

[1]  F. Gaita,et al.  Catheter Ablation vs. Anti-Arrhythmic Drugs as First-Line Treatment in Symptomatic Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials , 2021, Frontiers in Cardiovascular Medicine.

[2]  F. Crea Prediction of sudden death in the era of personalized medicine. , 2021, European heart journal.

[3]  F. D’Ascenzo,et al.  Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets , 2021, The Lancet.

[4]  V. Fuster,et al.  Machine Learning Improves Cardiovascular Risk Definition for Young, Asymptomatic Individuals. , 2020, Journal of the American College of Cardiology.

[5]  G. Breithardt,et al.  Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. , 2020, The New England journal of medicine.

[6]  Jeroen J. Bax,et al.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.

[7]  P. Kirchhof,et al.  Predicting recurrent atrial fibrillation after catheter ablation: a systematic review of prognostic models , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[8]  W. Rottbauer,et al.  Impact of re-definition of paroxysmal and persistent atrial fibrillation in the 2012 and 2016 European Society of Cardiology atrial fibrillation guidelines on outcomes after pulmonary vein isolation , 2020, Journal of Interventional Cardiac Electrophysiology.

[9]  L. Di Biase,et al.  Impact of atrial fibrillation catheter ablation on mortality, stroke, and heart failure hospitalizations: A meta‐analysis , 2020, Journal of cardiovascular electrophysiology.

[10]  G. Hindricks,et al.  Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial , 2019, JAMA.

[11]  W. Stevenson,et al.  Predictive Score for Identifying Survival and Recurrence Risk Profiles in Patients Undergoing Ventricular Tachycardia Ablation: The I-VT Score , 2018, Circulation. Arrhythmia and electrophysiology.

[12]  F. Gaita,et al.  Very long-term outcome following transcatheter ablation of atrial fibrillation. Are results maintained after 10 years of follow up? , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[13]  L. Jordaens,et al.  Catheter Ablation for Atrial Fibrillation with Heart Failure , 2018, The New England journal of medicine.

[14]  Kipp W. Johnson,et al.  Machine learning in cardiovascular medicine: are we there yet? , 2018, Heart.

[15]  J. Brachmann,et al.  Predictors of Atrial Fibrillation Recurrence after Catheter Ablation: Data from the German Ablation Registry , 2017, Scientific Reports.

[16]  G. Hindricks,et al.  Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry , 2017, European heart journal.

[17]  Andrew E. Darby,et al.  Recurrent Atrial Fibrillation After Catheter Ablation: Considerations For Repeat Ablation And Strategies To Optimize Success. , 2016, Journal of atrial fibrillation.

[18]  S. Pocock,et al.  Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. , 2016, The New England journal of medicine.

[19]  Jay A. Montgomery,et al.  The APPLE score: a novel and simple score for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation , 2014, Clinical Research in Cardiology.

[20]  R. Hunter,et al.  Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation?: a meta-analysis. , 2013, International journal of cardiology.

[21]  Prashanthan Sanders,et al.  Long‐term Outcomes of Catheter Ablation of Atrial Fibrillation: A Systematic Review and Meta‐analysis , 2013, Journal of the American Heart Association.

[22]  R. Winkle,et al.  Atrial arrhythmia burden on long-term monitoring in asymptomatic patients late after atrial fibrillation ablation. , 2012, The American journal of cardiology.

[23]  Ethan M Balk,et al.  Predictors of Atrial Fibrillation Recurrence After Radiofrequency Catheter Ablation: A Systematic Review , 2010, Cardiovascular Electrophysiology.

[24]  Jeroen J. Bax,et al.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[25]  M. Domanski,et al.  Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study , 2004, Circulation.